- Todos > Medicine Access and Rational Use > Supply Management
- Todos > Quality and Safety: Medicines > Safety and Efficacy
- Palabras clave > adverse event (AE)
- Palabras clave > evidence-based design (EBD)
- Palabras clave > infrastructure - building site infrastructure
- Palabras clave > patient safety
- Palabras clave > pharmacies - design guidelines
- Palabras clave > pharmacy - organisation and management
- Palabras clave > pharmacy management
(2010; 5 pages)
National statistics indicate that more than 1.5 million preventable medication related adverse events occur each year in the US, with costs of more than $177 billion annually for associated care.
Opportunities for errors are often a result of latent conditions, which are the inevitable "resident pathogens" within the system. They arise from decisions made by designers, builders, procedure writers, and top level management (Reason, 2000). In pharmacies, latent conditions can include noise, lighting, interruptions and distractions, and volume of prescriptions filled per hour. Latent errors can often be reduced through environmental design interventions.
The notion of using design to affect outcomes is not necessarily new, but a process of using the best available research to inform decision making in facility design is still gaining traction. This growing trend is called evidence-based design (EBD), which is defined as the process of basing decisions about the built environment on credible research to achieve the best possible outcomes